Fear Circuitry - The Brain's Alarm System

- Amygdala: Central processing hub; rapidly detects threats from sensory input (thalamus) and assigns fear value.
- Prefrontal Cortex (PFC): The "brake." Exerts top-down inhibitory control over the amygdala, assessing and dampening fear responses.
- Hippocampus: Provides context to fear-provoking stimuli; links fear to specific situations.
- Hypothalamus & Brainstem: Execute the physiological fear output (fight-or-flight).
⭐ In anxiety disorders, ↓ PFC activity fails to inhibit an overactive amygdala, resulting in an exaggerated and poorly controlled fear response.
Chemical Imbalance - Neurotransmitter Chaos
- Serotonin (5-HT): ↓ levels are central to anxiety pathophysiology.
- SSRIs & SNRIs are first-line treatments; they ↑ synaptic 5-HT.
- Affects mood, sleep, and appetite regulation, all disturbed in anxiety.
- Norepinephrine (NE): ↑ activity, especially from the Locus Coeruleus (LC).
- Drives autonomic symptoms: tachycardia, tremors, sweating.
- SNRIs also target NE reuptake.
- GABA (γ-aminobutyric acid): ↓ function of this primary inhibitory neurotransmitter.
- Leads to neuronal hyperexcitability.
- Benzodiazepines enhance GABA-A receptor function.
- Glutamate: ↑ levels of the primary excitatory neurotransmitter can be anxiogenic.
⭐ The Locus Coeruleus (LC) is the principal site for norepinephrine synthesis in the brain. Overactivation of the LC is strongly linked to the somatic and autonomic arousal seen in panic attacks.

Stress Response - The HPA Axis Overdrive
- Core Feature: Anxiety disorders are marked by a hyperactive Hypothalamic-Pituitary-Adrenal (HPA) axis.
- Initiation: The amygdala (fear center) over-stimulates the hypothalamus, initiating the stress cascade.
- Dysregulation: Chronic cortisol exposure impairs the negative feedback function of the hippocampus and prefrontal cortex (PFC), preventing the system from shutting down.
- Result: Persistently ↑ Corticotropin-Releasing Hormone (CRH), ↑ Adrenocorticotropic hormone (ACTH), and ↑ Cortisol.
⭐ In anxiety, failure of cortisol's negative feedback on the hypothalamus is a key mechanism. Dexamethasone suppression tests can reveal this non-suppression, indicating HPA axis hyperactivity.

Genetic Factors - Nature's Predisposition
- Family & Twin Studies: First-degree relatives show a 4-6x increased risk for anxiety disorders. Heritability is estimated at ~30-50%, with higher concordance in monozygotic than dizygotic twins.
- Key Gene Associations:
- SLC6A4: Gene for the serotonin transporter (SERT). The short (S) allele of the 5-HTTLPR promoter region is linked to reduced transporter expression and increased anxiety traits.
- BDNF: The Val66Met polymorphism can impair fear extinction circuitry.

⭐ The short allele of the serotonin transporter gene (5-HTTLPR) is linked to heightened amygdala reactivity to negative stimuli, forming a biological basis for vulnerability to stress.
- The amygdala is hyperactive, central to processing fear and anxiety signals.
- The prefrontal cortex (PFC) provides top-down inhibition of the amygdala, which is often deficient.
- Key neurotransmitters involved include ↑ norepinephrine, ↓ serotonin, and ↓ GABA.
- Benzodiazepines enhance GABAergic inhibition, while SSRIs modulate serotonin levels.
- The locus coeruleus, the principal site for norepinephrine synthesis, shows increased activity.
- The HPA axis can be dysregulated, leading to altered cortisol levels.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app